Burger, M; Thiounn, N; Denzinger, N et al.
ADJUVANT AUTOLOGOUS INTRAVESICAL MACROPHAGE CELL THERAPY VS. BCG FOR NON-MUSCLE INVASIVE BLADDER CANCER: A PHASE II, MULTICENTER, RANDOMIZED TRIALEUROPEAN UROLOGY SUPPLEMENTS. Bd. 8. H. 4. 2009 S. 285-285
Goetz, M; Kiesslich, R
Advanced imaging of the gastrointestinal tract: research vs. clinical tools?Curr Opin Gastroenterol. Bd. 25. H. 5. 2009 S. 412-21
West, M; Nicholls, K; Mehta, A et al.
Agalsidase Alfa and Kidney Dysfunction in Fabry DiseaseJ Am Soc Nephrol. Bd. 20. 2009 S. 1132-1139
Beck, M
Agalsidase alfa for the treatment of Fabry desease: new data on clinical efficacy and safetyExpert Opin Biol Ther. Bd. 9. H. 2. 2009 S. 255-261
Feriozzi, S; Schwarting, A; Sunder-Plassmann, G et al.
Agalsidase alfa slows the decline in renal function in patients with Fabry diseaseAm J Nephrol. Bd. 29. H. 5. 2009 S. 353-61
Timaru-Kast, R; Engelhard, K; Werner, C et al.
Age Dependent Differences of Neuronal Damage after Brain Trauma in MiceAnesthesiology. Bd. 111. 2009 S. CD A 1474
Gramley, F; Lorenzen, J; Knackstedt, C et al.
Age-related atrial fibrosis.AGE. Bd. 31. H. 1. 2009 S. 27-38
Hata, S; Fujishige, S; Araki, Y et al.
Alcadein cleavages by amyloid beta-precursor protein (APP) alpha gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunctionJ Biol Chem. Bd. 284. H. 52. 2009 S. 36024-33
Lagiou, P; Georgila, C; Minaki, P et al.
Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collectionEUROPEAN JOURNAL OF CANCER PREVENTION. Bd. 18. H. 1. 2009 S. 76-84
Fischbeck, S.; Hardt, J.
Algesimetrie in der ärztlichen VersorgungAngewandte Schmerztherapie und Palliativmedizin. Bd. 4. 2009 S. 32-35